RLMD
Relmada Therapeutics Inc
Price:  
0.63 
USD
Volume:  
297,692.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLMD EV/EBITDA

-
Upside

As of 2025-07-04, the EV/EBITDA ratio of Relmada Therapeutics Inc (RLMD) is -. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RLMD's latest enterprise value is 19.76 mil USD. RLMD's TTM EBITDA according to its financial statements is - mil USD. Dividing these 2 quantities gives us the above RLMD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative Enterprise Value.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.63 USD
Stock Price
- USD
Fair Price

RLMD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA